NASDAQ:XLRN - Acceleron Pharma Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$42.46 +0.69 (+1.65 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$41.77
Today's Range$41.36 - $42.69
52-Week Range$32.53 - $59.59
Volume504,851 shs
Average Volume613,991 shs
Market Capitalization$1.96 billion
P/E Ratio-15.84
Dividend YieldN/A

Analyst Ratings

Acceleron Pharma (NASDAQ:XLRN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for Acceleron Pharma in the last 12 months. Their average twelve-month price target is $56.20, suggesting that the stock has a possible upside of 32.36%. The high price target for XLRN is $75.00 and the low price target for XLRN is $33.00. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.702.702.642.55
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $56.20$56.20$56.30$51.50
Price Target Upside: 32.36% upside6.18% upside8.37% upside17.98% upside

Acceleron Pharma (NASDAQ:XLRN) Consensus Price Target History

Price Target History for Acceleron Pharma (NASDAQ:XLRN)

Acceleron Pharma (NASDAQ:XLRN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/3/2018HC WainwrightReiterated RatingBuy$72.00LowView Rating Details
9/17/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$52.00 ➝ $75.00HighView Rating Details
9/10/2018Morgan StanleyInitiated CoverageEqual Weight ➝ Equal Weight$55.00MediumView Rating Details
7/12/2018Royal Bank of CanadaReiterated RatingHold$48.00MediumView Rating Details
7/10/2018UBS GroupBoost Price TargetBuy$62.00HighView Rating Details
6/29/2018Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$55.00 ➝ $60.00HighView Rating Details
6/29/2018Goldman Sachs GroupUpgradeSell ➝ Neutral$21.00 ➝ $40.00HighView Rating Details
3/1/2018CitigroupBoost Price TargetBuy ➝ Positive$44.00 ➝ $63.00HighView Rating Details
2/28/2018BarclaysBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $54.00HighView Rating Details
2/26/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$33.00HighView Rating Details
1/8/2018OppenheimerReiterated RatingHoldMediumView Rating Details
6/14/2017InstinetReiterated RatingBuy$58.00LowView Rating Details
6/13/2017FBR & CoSet Price TargetBuy$63.00HighView Rating Details
6/13/2017CIBCDowngradeOutperform ➝ Market PerformLowView Rating Details
5/1/2017JMP SecuritiesReiterated RatingOutperform$39.00LowView Rating Details
3/1/2017NomuraInitiated CoverageBuyN/AView Rating Details
(Data available from 2/18/2017 forward)
This page was last updated on 2/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel